April Schultz

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Antiplatelet Therapy

Genetic Diversity

Coronary Artery Bypass Grafting

Cardiovascular Events

Top Venues

European journal of human genetics : EJHG

Journal of personalized medicine

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG 32 (8) (2024)
Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG 32 (8) (2024)
Amanda Massmann, Joel Van Heukelom, Max Weaver, April Schultz, Debbie M Figueroa, Adam Stys, Tomasz P Stys, Kurt D Christensen
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel. Pharmacogenomics (2024)
Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG 32 (8) (2024)
Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG 32 (8) (2024)
Amanda Massmann, Kurt D Christensen, Joel Van Heukelom, April Schultz, Muhammad Hamza Saad Shaukat, Catherine Hajek, Max Weaver, Robert C Green, Ann Chen Wu, Madison R Hickingbotham, Emilie S Zoltick, Adam Stys, Tomasz P Stys
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. European journal of human genetics : EJHG (2024)
Savannah Collett, Amanda Massmann, Natasha J Petry, Joel Van Heukelom, April Schultz, Tadd Hellwig, Jordan F Baye
Metoprolol and CYP2D6 : A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. Journal of personalized medicine 13 (3) (2023)
Charlene L Preys, Carrie L Blout Zawatsky, Amanda Massmann, Joel Van Heukelom, Robert C Green, Catherine A Hajek, Madison R Hickingbotham, Emilie S Zoltick, April Schultz, Kurt D Christensen
Attitudes about pharmacogenomic testing vary by healthcare specialty. Pharmacogenomics (2023)
Savannah Collett, Amanda Massmann, Natasha J Petry, Joel Van Heukelom, April Schultz, Tadd Hellwig, Jordan F Baye
Metoprolol and CYP2D6 : A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. Journal of personalized medicine 13 (3) (2023)
Savannah Collett, Amanda Massmann, Natasha J Petry, Joel Van Heukelom, April Schultz, Tadd Hellwig, Jordan F Baye
Metoprolol and CYP2D6 : A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. Journal of personalized medicine 13 (3) (2023)